But of the few European countries compared, at least two have deregulated pricing for generics which is exactly the point we're talking about isn't it? The others may or may not (I don't know). But why were Norway, Sweden and Denmark omitted from that comparison when they are in every other comparison on the original page? It's a strange omission because generics in Scandinavia are lower than western Europe. Inside of Europe, countries that have deregulated their generics simply have higher prices.